Clinical trials
Terminated Hematologic Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
58 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 4 |
| 2008 | 4 |
| 2010 | 4 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 6 |
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 4 |
| 2018 | 4 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 4 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 58 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Seagen Inc. | 6 |
| M.D. Anderson Cancer Center | 5 |
| Ariad Pharmaceuticals | 2 |
| CTI BioPharma | 2 |
| Celgene | 2 |
| Emory University | 2 |
| Fred Hutchinson Cancer Center | 2 |
| Pfizer | 2 |
| Shionogi | 2 |
| AO GENERIUM | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hematologic Diseases | 58 |
| Neoplasms | 11 |
| Leukemia | 9 |
| Bone Marrow Diseases | 8 |
| Myeloproliferative Disorders | 8 |
| Anemia, Sickle Cell | 7 |
| Lymphoma, Large B-Cell, Diffuse | 7 |
| Lymphoproliferative Disorders | 7 |
| Neoplasms by Histologic Type | 7 |
| Immune System Diseases | 6 |
Trials
Showing 51 to 58 of 58. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.